Interventional oncology market to be valued at $4.24b by 2029

One key driver is the increasing burden of cancer.

The interventional oncology market is projected to reach $4.24b by 2029 at a compound annual growth rate of 9%, said MarketsandMarkets.

The sector’s expansion is attributed to the increasing global burden of cancer and the demand for minimally invasive treatment options.

Moreover, procedures such as transarterial chemoembolisation, transcatheter arterial radioembolisation, and percutaneous ablation, are seeing higher adoption due to their role in treating various cancers.

“Greater preference for out-patient or day-care procedure due to higher cost-effectiveness and convenience will further add to the acceptance,” the report said.